Document:

Exhibit
4.5

 

RIGHTS
AGREEMENT

 

This
Rights Agreement (this “Agreement”) is made as of [●], 2022 between PROTONIQ Acquisition Corp, a Cayman Islands exempted
company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, with offices at 1 State
Street, New York, New York 10004 (the “Right Agent”).

 

WHEREAS,
the Company has received a firm commitment from JonesTrading Institutional Services, LLC. (the “Representative”), as representative
of the several underwriters, to purchase up to an aggregate of 10,000,000 units, each unit (“Unit”) comprised of one Class
A Ordinary Share of the Company, par value $.0001 per share (the “Class A Ordinary Share”), one-half of one redeemable warrant
(“Public Warrant”) with each Public Warrant entitling the holder thereof to purchase one Class A Ordinary Share, and one
right to receive one-tenth of one Class A Ordinary Share (a “Public Right”) upon the happening of the triggering event described
herein, and in connection therewith, will issue and deliver up to an aggregate of 10,000,000 Public Rights upon consummation of such
public offering, with an option to purchase up to an additional 1,500,000 units from the Company which are attributable to the over-allotment
option (“Public Offering”);

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-1, File
No. 333-266342 (“Registration Statement”), for the registration, under the Securities Act of 1933, as amended (“Act”)
of, among other securities, the Public Rights and the Class A Ordinary Shares issuable to the holders of the Public Rights;

 

WHEREAS,
the Company desires the Right Agent to act on behalf of the Company, and the Right Agent is willing to so act, in connection with the
issuance, registration, transfer and exchange of the Rights;

 

WHEREAS,
the Company desires to provide for the form and provisions of the Rights, the terms upon which they shall be issued, and the respective
rights, limitation of rights, and immunities of the Company, the Right Agent, and the holders of the Rights; and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Rights, when executed on behalf of the Company and countersigned
by or on behalf of the Right Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the
execution and delivery of this Agreement.

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

	1.	Appointment
of Right Agent. The Company hereby appoints the Right Agent to act as agent for the Company for the Rights, and the Right Agent hereby
accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.

 

	2.	Rights.

 

	 	2.1.	Form
    of Right. Each Right shall be issued in registered or book entry form, as requested by the Company or the holder of a Right.
    Any Rights issued in registered form shall be in substantially the form of Exhibit A hereto, the provisions of which are incorporated
    herein and shall be signed by, or bear the facsimile signature of, the Chairman of the Board or Chief Executive Officer and Treasurer,
    Secretary or Assistant Secretary of the Company and shall bear a facsimile of the Company’s seal, if any. In the event the
    person whose facsimile signature has been placed upon any Right shall have ceased to serve in the capacity in which such person signed
    the Right before such Right is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date
    of issuance.
	 	 	 
	 	2.2.	Effect
    of Countersignature. Unless and until countersigned by the Right Agent pursuant to this Agreement, a registered Right shall be
    invalid and of no effect and may not be exchanged for Class A Ordinary Shares.

     

 

    	 

    	 

    

 

	 	2.3.	Registration.

 

	 	2.3.1.	Right
    Register. The Right Agent shall maintain books (“Right Register”) for the registration of original issuance and the
    registration of transfer of the Rights. Upon the initial issuance of the Rights, the Right Agent shall issue and register the Rights
    in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions delivered to the
    Right Agent by the Company.
	 	 	 
	 	2.3.2.	Registered
    Holder. Prior to due presentment for registration of transfer of any Right, the Company and the Right Agent may deem and treat
    the person in whose name such Right shall be registered upon the Right Register (“registered holder”) as the absolute
    owner of such Right and of each Right represented thereby (notwithstanding any notation of ownership or other writing on the Right
    Certificate made by anyone other than the Company or the Right Agent), for the purpose of the exchange thereof, and for all other
    purposes, and neither the Company nor the Right Agent shall be affected by any notice to the contrary.

 

	 	2.4.	Detachability
    of Rights. The securities comprising the Units, including the Rights, will not be separately transferable until the fifty-second
    (52nd) day after the date hereof unless the Representative informs the Company and the Right Agent of its decision to allow earlier
    separate trading, but in no event will separate trading of the securities comprising the Units begin until (i) the Company files
    a Current Report on Form 8-K which includes an audited balance sheet reflecting the receipt by the Company of the gross proceeds
    of the Public Offering including the proceeds received by the Company from the exercise of the over-allotment option, if the over-allotment
    option is exercised on the date hereof, and (ii) the Company issues a press release and files a Current Report on Form 8-K announcing
    when such separate trading shall begin.

 

	3.	Terms
    and Exchange of Rights.

 

	 	3.1.	Rights.
    Each Right shall entitle the holder thereof to receive one-tenth of one Class A Ordinary Share upon the happening of the Exchange
    Event (described below). No additional consideration shall be paid by a holder of Rights in order to receive his, her or its Class
    A Ordinary Share upon the Exchange Event as the purchase price for such one Class A Ordinary Share has been included in the purchase
    price for the Units. In no event will the Company be required to net cash settle the Rights or issue fractional one Class A Ordinary
    Shares. The provisions of this Section 3.1 may not be modified, amended or deleted without the prior written consent of the Representative.
	 	 	 
	 	3.2.	Exchange
    Event. The Exchange Event shall be the Company’s consummation of an initial Business Combination (as defined in the Company’s
    Amended and Restated Memorandum and Articles of Association). 
	 	 	 
	 	3.3.	Exchange
    of Rights.

 

	 	3.3.1.	Issuance
    of Class A Ordinary Shares. As soon as practicable upon the occurrence of an Exchange Event, the Company shall direct holders
    of the Rights to return their Rights Certificates to the Right Agent. Upon receipt of a valid Rights Certificate, the Company shall
    issue to the registered holder of such Right(s) the number of full Class A Ordinary Shares to which he, she or it is entitled, registered
    in such name or names as may be directed by him, her or it and issue to such registered holder(s) a certificate or book-entry position
    for the such shares. Notwithstanding the foregoing, or any provision contained in this Agreement to the contrary, in no event will
    the Company be required to net cash settle the Rights. The Company shall not issue fractional shares upon exchange of Rights. In
    the event that any holder would otherwise be entitled to any fractional share upon exchange of Rights, at the time of an Exchange
    Event, the Company will instruct the Right Agent how any such entitlement will be addressed. To the fullest extent permitted by the
    Company’s Amended and Restated Memorandum and Articles of Association the Company reserves the right to deal with any such
    fractional entitlement at the relevant time in any manner permitted by the Act and the Amended and Restated Memorandum and Articles,
    which would include the rounding down of any entitlement to receive Class A Ordinary Shares to the nearest whole share (and in effect
    extinguishing any fractional entitlement), or the holder being entitled to hold any remaining fractional entitlement (without any
    share being issued) and to aggregate the same with any future fractional entitlement to receive shares in the Company until the holder
    is entitled to receive a whole number. Any rounding down and extinguishment may be done with or without any in lieu cash payment
    or other compensation being made to the holder of the relevant Rights, such that value received on exchange of the Rights may be
    considered less than the value that the holder would otherwise expect to receive.

 

    	 

    	 

    

 

	 	3.3.2.	Valid
    Issuance. All Class A Ordinary Shares issued upon an Exchange Event in conformity with this Agreement and the Amended and Restated
    Memorandum and Articles of Association of the Company shall be validly issued, fully paid and nonassessable.
	 	 	 
	 	3.3.3.	Date
    of Issuance. Each person in whose name any such certificate or book-entry position for Class A Ordinary Shares is issued shall
    for all purposes be deemed to have become the holder of record of such shares on the date of the Exchange Event, irrespective of
    the date of delivery of such certificate or entry of position.
	 	 	 
	 	3.3.4.	Company
    Not Surviving Following Exchange Event. If the Exchange Event results in the Company not continuing as a publicly held reporting
    entity, the definitive agreement will provide for the holders of Rights to receive the same per share consideration as the holders
    of the Class A Ordinary Share will receive in with the Exchange Event, for the number of shares such holder is entitled to pursuant
    to Section 3.1 above.

 

	 	3.4.	Duration
    of Rights. If an Exchange Event does not occur within the time period set forth in the Company’s Amended and Restated Memorandum
    and Articles of Association, as the same may be amended from time to time, the Rights shall expire and shall be worthless.

 

	4.	Transfer
    and Exchange of Rights.

 

	 	4.1.	Registration
    of Transfer. The Right Agent shall register the transfer, from time to time, of any outstanding Right upon the Right Register,
    upon surrender of such Right for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions
    for transfer. Upon any such transfer, a new Right representing an equal aggregate number of Rights shall be issued and the old Right
    shall be cancelled by the Right Agent.
	 	 	 
	 	4.2.	Procedure
    for Surrender of Rights. Rights may be surrendered to the Right Agent, together with a written request for exchange or transfer,
    and thereupon the Right Agent shall issue in exchange therefor one or more new Rights as requested by the registered holder of the
    Rights so surrendered, representing an equal aggregate number of Rights; provided, however, that in the event that a Right surrendered
    for transfer bears a restrictive legend, the Right Agent shall not cancel such Right and issue new Rights in exchange therefor until
    the Right Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether
    the new Rights must also bear a restrictive legend.
	 	 	 
	 	4.3.	Fractional
    Rights. The Right Agent shall not be required to effect any registration of transfer or exchange which will result in the issuance
    of a Right Certificate for a fraction of a Right.
	 	 	 
	 	4.4.	Service
    Charges. There shall be a reasonable service charge paid to the Right Agent for any exchange or registration of transfer of Rights.
	 	 	 
	 	4.5.	Right
    Execution and Countersignature. The Right Agent is hereby authorized to countersign and to deliver, in accordance with the terms
    of this Agreement, the Rights required to be issued pursuant to the provisions of this Section 4, and the Company, whenever required
    by the Right Agent, will supply the Right Agent with Rights duly executed on behalf of the Company for such purpose.

 

    	 

    	 

    

 

	5.	Other
    Provisions Relating to Rights of Holders of Rights.

 

	 	5.1.	No
    Rights as Shareholder. Until exchange of a Right for Class A Ordinary Share as provided for herein, a Right does not entitle
    the registered holder thereof to any of the rights of a shareholder of the Company, including, without limitation, the right to receive
    dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as shareholders in respect
    of the meetings of shareholders or the election of directors of the Company or any other matter.
	 	 	 
	 	5.2.	Lost,
    Stolen, Mutilated, or Destroyed Rights. If any Right is lost, stolen, mutilated, or destroyed, the Company and the Right Agent
    may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Right,
    include the surrender thereof), issue a new Right of like denomination, tenor, and date as the Right so lost, stolen, mutilated,
    or destroyed. Any such new Right shall constitute a substitute contractual obligation of the Company, whether or not the allegedly
    lost, stolen, mutilated, or destroyed Right shall be at any time enforceable by anyone.
	 	 	 
	 	5.3.	Reservation
    of Class A Ordinary Shares. The Company shall at all times reserve and keep available a number of its authorized but unissued
    Class A Ordinary Shares that will be sufficient to permit the exchange of all outstanding Rights issued pursuant to this Agreement.

 

	6.	Concerning
    the Right Agent and Other Matters.

 

	 	6.1.	Payment
    of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Right
    Agent in respect of the issuance or delivery of Class A Ordinary Share upon the exchange of Rights, but the Company shall not be
    obligated to pay any transfer taxes in respect of the Rights or such Class A Ordinary Shares.
	 	 	 
	 	6.2.	Resignation,
    Consolidation, or Merger of Right Agent.

 

	 	6.2.1.	Appointment
    of Successor Right Agent. The Right Agent, or any successor to it hereafter appointed, may resign its duties and be discharged
    from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office
    of the Right Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor
    Right Agent in place of the Right Agent. If the Company shall fail to make such appointment within a period of 30 days after it has
    been notified in writing of such resignation or incapacity by the Right Agent or by the holder of the Right (who shall, with such
    notice, submit his, her or its Right for inspection by the Company), then the holder of any Right may apply to the Supreme Court
    of the State of New York for the County of New York for the appointment of a successor Right Agent at the Company’s cost. Any
    successor Right Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing under the
    laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New
    York, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state
    authority. After appointment, any successor Right Agent shall be vested with all the authority, powers, rights, immunities, duties,
    and obligations of its predecessor Right Agent with like effect as if originally named as Right Agent hereunder, without any further
    act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Right Agent shall execute and deliver, at
    the expense of the Company, an instrument transferring to such successor Right Agent all the authority, powers, and rights of such
    predecessor Right Agent hereunder; and upon request of any successor Right Agent the Company shall make, execute, acknowledge, and
    deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Right Agent
    all such authority, powers, rights, immunities, duties, and obligations.

 

    	 

    	 

    

 

	 	6.2.2.	Notice
    of Successor Right Agent. In the event a successor Right Agent shall be appointed, the Company shall give notice thereof to the
    predecessor Right Agent and the transfer agent for the Class A Ordinary Shares not later than the effective date of any such appointment.
	 	 	 
	 	6.2.3.	Merger
    or Consolidation of Right Agent. Any corporation into which the Right Agent may be merged or with which it may be consolidated
    or any corporation resulting from any merger or consolidation to which the Right Agent shall be a party shall be the successor Right
    Agent under this Agreement without any further act.

     

 

	 	6.3.	Fees
    and Expenses of Right Agent.

 

	 	6.3.1.	Remuneration.
    The Company agrees to pay the Right Agent reasonable remuneration for its services as such Right Agent hereunder and will reimburse
    the Right Agent upon demand for all expenditures that the Right Agent may reasonably incur in the execution of its duties hereunder.
	 	 	 
	 	6.3.2.	Further
    Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged,
    and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Right Agent for the
    carrying out or performing of the provisions of this Agreement.

 

	 	6.4.	Liability
    of Right Agent.

 

	 	6.4.1.	Reliance
    on Company Statement. Whenever in the performance of its duties under this Agreement, the Right Agent shall deem it necessary
    or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such
    fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved
    and established by a statement signed by the Chief Executive Officer or Chief Financial Officer and delivered to the Right Agent.
    The Right Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant to the provisions of this
    Agreement.
	 	 	 
	 	6.4.2.	Indemnity.
    The Right Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith. The Company agrees
    to indemnify the Right Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable counsel
    fees, for anything done or omitted by the Right Agent in the execution of this Agreement except as a result of the Right Agent’s
    gross negligence, willful misconduct, or bad faith.
	 	 	 
	 	6.4.3.	Exclusions.
    The Right Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution
    of any Right (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or
    condition contained in this Agreement or in any Right; nor shall it by any act hereunder be deemed to make any representation or
    warranty as to the authorization or reservation of any Class A Ordinary Shares to be issued pursuant to this Agreement or any Right
    or as to whether any Class A Ordinary Shares will, when issued, be valid and fully paid and nonassessable.

 

    	 

    	 

    

 

	 	6.5.	Acceptance
    of Agency. The Right Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms
    and conditions herein set forth.
	 	 	 
	 	6.6.	Waiver.
    The Right Agent hereby waives any right of set-off or any other right, title, interest or claim of any kind (“Claim”)
    in, or to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the
    date hereof, by and between the Company and the Right Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement,
    payment or satisfaction for any Claim against the Trust Account for any reason whatsoever.

 

	7.	Miscellaneous
    Provisions.

 

	 	7.1.	Successors.
    All the covenants and provisions of this Agreement by or for the benefit of the Company or the Right Agent shall bind and inure to
    the benefit of their respective successors and assigns.
	 	 	 
	 	7.2.	Notices.
    Any notice, statement or demand authorized by this Agreement to be given or made by the Right Agent or by the holder of any Right
    to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail
    or private courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed
    in writing by the Company with the Right Agent), as follows:

 

	 	PROTONIQ
    Acquisition Corp

    One
    World Trade Center

    Suite
    8500

    New
    York, New York 10007

    Attn:
    Babar Ali, Chief Executive Officer

     

    Any
    notice, statement or demand authorized by this Agreement to be given or made by the holder of any Right or by the Company to or on
    the Right Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private
    courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing
    by the Right Agent with the Company), as follows:

     

    Continental
    Stock Transfer & Trust Company

	 	1
    State Street
	 	New
    York, NY 10004
	 	Attn:
    Francis Wolf
	 	 
	 	with
    a copy to:
	 	 

    Nelson
    Mullins Riley & Scarborough LLP

	 	101
    Constitution Avenue, NW. Suite 900
	 	Washington,
    D.C. 20001
	 	Attn:
    Andrew M. Tucker, Esq.
	 	 
	 	and

     

    PROTONIQ
    Acquisition Corp

    One
    World Trade Center

    Suite
    8500

    New
    York, New York 10007

    Attn:
    Babar Ali, Chief Executive Officer

 

    	 

    	 

    

 

	 	7.3.	Applicable
    Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Rights shall be governed
    in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the
    application of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against
    it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or
    the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
    shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient
    forum. Any such process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified
    mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 7.2 hereof. Such mailing shall
    be deemed personal service and shall be legal and binding upon the Company in any action, proceeding or claim. Notwithstanding the
    foregoing, (i) the provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by the Exchange
    Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum, and
    (ii) unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States
    of America shall, to the full extent permitted by law, be the exclusive form for the resolution of any complaint asserting a cause
    of action arising under the Securities Act or the rules and regulations promulgated thereunder.

     

    Any
    person or entity purchasing or otherwise acquiring any interest in the Rights shall be deemed to have notice of and to have consented
    to the forum provisions in this Section 7.3. If any action, the subject matter of which is within the scope the forum provisions
    above, is filed in a court other than a court located within the State of New York or the United States District Court for the Southern
    District of New York (a “foreign action”) in the name of the holder of any Right, such holder shall be deemed
    to have consented to: (x) the personal jurisdiction of the state and federal courts located within the State of New York or the United
    States District Court for the Southern District of New York in connection with any action brought in any such court to enforce the
    forum provisions (an “enforcement action”), and (y) having service of process made upon such holder in any such
    enforcement action by service upon such holder’s counsel in the foreign action as agent for such holder.

	 	 	 
	 	7.4.	Persons
    Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any of the provisions
    hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and
    the registered holders of the Rights and, for the purposes of Sections 3.1, 7.4 and 7.8 hereof, the Representative, any right, remedy,
    or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. The Representative
    shall be deemed to be a third-party beneficiary of this Agreement with respect to Sections 3.1, 7.4 and 7.8 hereof. All covenants,
    conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive benefit of the
    parties hereto (and the Representative with respect to Sections 3.1, 7.4 and 7.8 hereof) and their successors and assigns and of
    the registered holders of the Rights.
	 	 	 
	 	7.5.	Examination
    of this Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Right Agent in the
    County of New York, State of New York, for inspection by the registered holder of any Right. The Right Agent may require any such
    holder to submit his, her or its Right for inspection by it.
	 	 	 
	 	7.6.	Counterparts.
    This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes
    be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.
	 	 	 
	 	7.7.	Effect
    of Headings. The Section headings herein are for convenience only and are not part of this Agreement and shall not affect the
    interpretation thereof.
	 	7.8.	Amendments.
    This Agreement may be amended by the parties hereto without the consent of any registered holder for the purpose of curing any ambiguity,
    or of curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions with
    respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties
    deem shall not adversely affect the interest of the registered holders. All other modifications or amendments shall require the written
    consent or vote of the registered holders of a majority of the then outstanding Rights. The provisions of this Section 7.8 may not
    be modified, amended or deleted without the prior written consent of the Representative.
	 	 	 
	 	7.9.	Severability.
    This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect
    the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid
    or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as
    similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

[Signature
Page Follows]

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	PROTONIQ
    ACQUISITION CORP.
	 	 
	 	By:	/s/
	 	Name:	 Babar Ali
	 	Title:	Chief Executive Officer
	 	 	 
	 	CONTINENTAL
    STOCK TRANSFER & TRUST COMPANY
	 	 	 
	 	By:	/s/
	 	Name:	Michael Goedecke
	 	Title:	 Vice President

 

[Signature
page to Rights Agreement between PROTONIQ Acquisition Corp and

Continental
Stock Transfer & Trust Company]

 

    	 

    	 

    

 

EXHIBIT
A

 

Form
of Right

 

(attached)Exhibit
10.1

 

[●],
2022

 

PROTONIQ
Acquisition Corp

One
World Trade Center,

Suite
8500,

New
York, New York 10007

 

Re:
Initial Public Offering

 

Ladies
and Gentlemen:

 

This
letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting
Agreement”) to be entered into by and between PROTONIQ Acquisition Corp, a Cayman Islands exempted company with registration number
388159 (the “Company”) and JonesTrading Institutional Services LLC, as representative of the underwriters (each, an “Underwriter”
and collectively, the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”),
of up to 11,500,000 of the Company’s units (including up to 1,500,000 units that may be purchased to cover over-allotments, if
any) (the “Units”), each comprised of one of the Company’s Class A ordinary shares, par value $0.0001 per share (the
“Ordinary Shares”), one-half of one redeemable warrant and one right. Each redeemable warrant (each, a “Warrant”)
entitles the holder thereof to purchase one-half of one Ordinary Share at a price of $11.50 per share, subject to adjustment. Each right
(each, a “Right”) entitles the holder thereof to receive one-tenth (1/10) of one Ordinary Share upon consummation of our
initial business combination. The Units shall be sold in the Public Offering pursuant to a registration statement on Form S-1 and prospectus
(the “Prospectus”) filed by the Company with the Securities and Exchange Commission (the “Commission”) and the
Units have been approved to be listed on the Nasdaq Global Market. Certain capitalized terms used herein are defined in paragraph 11
hereof.

 

In
order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the Public Offering and
for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, PROTONIQ LLC (the “Sponsor”)
and each of the undersigned individuals, each of whom is a member of the Company’s board of directors and/or management team (each,
an “Insider” and collectively, the “Insiders”), hereby agrees with the Company as follows:

 

1.
The Sponsor and each Insider agrees that if the Company seeks shareholder approval of a proposed Business Combination, then in
connection with such proposed Business Combination, it, he or she shall (i) vote any shares of Capital Stock owned by it, him or her
in favor of any proposed Business Combination and (ii) not redeem any Ordinary Shares owned by it, him or her in connection with such
shareholder approval. If the Company engages in a tender offer in connection with any proposed Business Combination, each Insider
agrees that it, he or she will not seek to sell its, his or her Ordinary Shares to the Company in connection with such tender offer.

 

    		1	 

    	 

    

 

2.
The Sponsor and each Insider hereby agrees that in the event that the Company fails to consummate a Business Combination within 12 months
from the closing of the Public Offering (or up to 18 months from the closing of the Public Offering if the Company extends the period
of time to consummate a Business Combination, as described in more detail in the Prospectus) or such later period approved in accordance
with the Company’s amended and restated memorandum and articles of association, the Sponsor and each Insider shall take
all reasonable steps to cause the Company to (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably
possible but not more than 10 business days thereafter, subject to lawfully available funds therefor, redeem 100% of the Ordinary Shares
sold as part of the Units in the Public Offering (the “Offering Shares”), at a per-share price, payable in cash, equal to
the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously
released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then
outstanding Offering Shares, which redemption will completely extinguish all Public Shareholders’ rights as shareholders
of the Company (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as
promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders
and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware
law to provide for claims of creditors and other requirements of applicable law. The Sponsor and each Insider agree not to propose any
amendment to the Company’s amended and restated memorandum and articles of association that would modify (i) the substance
or timing of the Company’s obligation to redeem 100% of the Offering Shares if the Company does not complete a Business Combination
within 12 months from the closing of the Public Offering (or up to 18 months from the closing of the Public Offering if the Company extends
the period of time to consummate a Business Combination, as described in more detail in the Prospectus) or (ii) the other provisions
relating to shareholders’ rights or pre-initial business combination activities, unless the Company provides its Public
Shareholders with the opportunity to redeem their Offering Shares upon approval of any such amendment at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of amounts
released for payment of taxes) divided by the number of then outstanding Offering Shares. The Sponsor and each Insider agree to waive
its redemption rights with respect to shares of Capital Stock owned by it in connection with a shareholder vote to approve an
amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing
of the Company’s obligation to redeem 100% of the Offering Shares if the Company does not complete a Business Combination within
12 months from the closing of the Public Offering (or up to 18 months from the closing of the Public Offering if the Company extends
the period of time to consummate a Business Combination, as described in more detail in the Prospectus) or (B) with respect to any other
provision relating to shareholders’ rights or pre-initial business combination activity.

 

Each
of the Sponsor and each Insider acknowledges that it, he or she has no right, title, interest or claim of any kind in or to any monies
held in the Trust Account or any other asset of the Company as a result of any liquidation of the Company with respect to the Founder
Shares held by it, him or her. The Sponsor and each Insider hereby further waives, with respect to any Ordinary Shares held by it, him
or her, if any, any redemption rights it, he or she may have in connection with the consummation of a Business Combination, including,
without limitation, any such rights available in the context of a shareholder vote to approve such Business Combination or in
the context of a tender offer made by the Company to purchase Ordinary Shares (although the Sponsor, the Insiders and their respective
affiliates shall be entitled to redemption and liquidation rights with respect to any Offering Shares it or they hold if the Company
fails to consummate a Business Combination within 12 months from the date of the closing of the Public Offering (or up to 18 months from
the closing of the Public Offering if the Company extends the period of time to consummate a Business Combination, as described in more
detail in the Prospectus).

 

    		2	 

    	 

    

 

3.
During the period commencing on the effective date of the Underwriting Agreement and ending 180 days after such date, the Sponsor
and each Insider shall not, without the prior written consent of the Representative, (i) sell, offer to sell, contract or agree to
sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, or
establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the Commission
promulgated thereunder, with respect to any Units, Ordinary Shares, Warrants, Rights or any securities convertible into, or
exercisable, or exchangeable for, Ordinary Shares owned by it, him or her, (ii) enter into any swap or other arrangement that
transfers to another, in whole or in part, any of the economic consequences of ownership of any Units, Ordinary Shares, Warrants,
Rights or any securities convertible into, or exercisable, or exchangeable for, Ordinary Shares owned by it, him or her, whether any
such transaction is to be settled by delivery of such securities, in cash or otherwise, or (iii) publicly announce any intention to
effect any transaction specified in clause (i) or (ii). Each of the Insiders and the Sponsor acknowledges and agrees that, prior to
the effective date of any release or waiver, of the restrictions set forth in this paragraph 3 or paragraph 7 below, the Company
shall announce the impending release or waiver by press release through a major news service at least two business days before the
effective date of the release or waiver. Any release or waiver granted shall only be effective two business days after the
publication date of such press release. The provisions of this paragraph will not apply if the release or waiver is effected solely
to permit a transfer not for consideration and the transferee has agreed in writing to be bound by the same terms described in this
Letter Agreement to the extent and for the duration that such terms remain in effect at the time of the transfer.

 

4.
In the event of the liquidation of the Trust Account, the Sponsor (which for purposes of clarification shall not extend to any other
shareholders, members or managers of the Sponsor) agrees to indemnify and hold harmless the Company against any and all loss,
liability, claim, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably incurred
in investigating, preparing or defending against any litigation, whether pending or threatened, or any claim whatsoever) to which the
Company may become subject as a result of any claim by (i) any third party (other than the Company’s independent accountants) for
services rendered or products sold to the Company or (ii) a prospective target business with which the Company has entered into a letter
of intent, confidentiality or other similar agreement for a Business Combination (a “Target”); provided, however, that such
indemnification of the Company by the Sponsor shall apply only to the extent necessary to ensure that such claims by a third party for
services rendered (other than the Company’s independent public accountants) or products sold to the Company or a Target do not
reduce the amount of funds in the Trust Account to below (i) $10.30 per share of the Offering Shares or (ii) such lesser amount per share
of the Offering Shares held in the Trust Account due to reductions in the value of the trust assets as of the date of the liquidation
of the Trust Account, in each case, net of the amount of interest earned on the property in the Trust Account which may be withdrawn
to pay taxes, except as to any claims by a third party (including a Target) who executed a waiver of any and all rights to seek access
to the Trust Account and except as to any claims under the Company’s indemnity of the Underwriters against certain liabilities,
including liabilities under the Securities Act. In the event that any such executed waiver is deemed to be unenforceable against such
third party, the Sponsor shall not be responsible to the extent of any liability for such third party claims. The Sponsor shall have
the right to defend against any such claim with counsel of its choice reasonably satisfactory to the Company if, within 15 days following
written receipt of notice of the claim to the Sponsor, the Sponsor notifies the Company in writing that it shall undertake such defense.

 

    		3	 

    	 

    

 

5.
To the extent that the Underwriters do not exercise their over-allotment option to purchase up to an additional 1,500,000 Units within
45 days from the date of the Prospectus (and as further described in the Prospectus), the Sponsor agrees to forfeit, at no cost, a number
of Founder Shares in the aggregate equal to the product of 375,000 multiplied by a fraction, (i) the numerator of which is 1,500,000
minus the number of Units purchased by the Underwriters upon the exercise of their over-allotment option, and (ii) the denominator of
which is 1,500,000. The forfeiture will be adjusted to the extent that the over-allotment option is not exercised in full by the Underwriters
so that the Initial Shareholders will own an aggregate of 20.0% of the Company’s issued and outstanding Ordinary Shares
after the Public Offering (excluding the Private Placement Units).

 

6.
The Sponsor and each Insider hereby agrees and acknowledges that: (i) the Underwriters and the Company would be irreparably injured
in the event of a breach by such Sponsor or an Insider of its, his or her obligations under paragraphs 1, 2, 3, 4, 5, 6, 7(a), 7(b),
and 9 of this Letter Agreement (ii) monetary damages may not be an adequate remedy for such breach and (iii) the non-breaching party
shall be entitled to injunctive relief, in addition to any other remedy that such party may have in law or in equity, in the event
of such breach.

 

7.
(a) The Sponsor and each Insider agrees that it or he shall not Transfer any Founder Shares (or Ordinary Shares issuable upon conversion
thereof) until the earlier of (A) six months after the date of the Company’s initial Business Combination or (B) subsequent to
the Company’s initial Business Combination, (x) if the reported last sale price of the Class A Ordinary Share equals or
exceeds $12.00 per share (as adjusted for stock splits, stock dividends, right issuances, reorganizations, recapitalizations and the
like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business
Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar
transaction that results in all of our shareholders having the right to exchange their Ordinary Shares for cash, securities or
other property (the “Founder Shares Lock-up Period”).

 

(b)
The Sponsor and each Insider agrees that it, he or she shall not Transfer any Private Placement Units, the Private Placement Shares,
the Private Placement Warrants or Ordinary Shares issued or issuable upon the exercise of the Private Placement Warrants, until 30
days after the completion of the initial Business Combination (the “Private Placement Units Lock-up Period”, together
with the Founder Shares Lock-up Period, the “Lock-up Periods”).

 

    		4	 

    	 

    

 

(c)
Notwithstanding the provisions set forth in paragraphs 7(a) and 7(b), Transfers of the Founder Shares, Private Placement Units, Private
Placement Shares, Private Placement Warrants, Private Placement Rights and Ordinary Shares issued or issuable upon the exercise or conversion
of the Private Placement Warrants and Private Placement Rights or the Founder Shares that are held by the Sponsor, any Insider or any
of their permitted transferees (that have complied with this paragraph 7(c)), are permitted (i) to the Company’s officers or directors,
any affiliate or family member of any of the Company’s officers or directors or any members of the Sponsor or any affiliates of
the Sponsor; (b) in the case of an individual, by gift to a member of such individual’s immediate family or to a trust, the beneficiary
of which is a member of such individual’s immediate family, an affiliate of such individual or to a charitable organization; (c)
in the case of an individual, by virtue of laws of descent and distribution upon death of such individual; (d) in the case of an individual,
pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with the consummation of an initial
Business Combination at prices no greater than the price at which the securities were originally purchased; (f) in the event of the Company’s
liquidation prior to the completion of an initial Business Combination; (g) by virtue of the laws of the State of Delaware or the Sponsor’s
limited liability company agreement upon dissolution of the Sponsor; or (h) in the event of the Company’s liquidation, merger,
capital stock exchange, reorganization or other similar transaction which results in all of the Company’s shareholders having
the right to exchange their Ordinary Shares for cash, securities or other property subsequent to the Company’s completion of an
initial Business Combination; provided, however, that in the case of clauses (a) through (e) or (g), these permitted transferees must
enter into a written agreement with the Company agreeing to be bound by the transfer restrictions herein and the other restrictions contained
in this Agreement (including provisions relating to voting, the Trust Account and liquidating distributions).

 

8.
Each of the Sponsor and the Insiders represents and warrants that it, he or she has never been suspended or expelled from membership
in any securities or commodities exchange or association or had a securities or commodities license or registration denied,
suspended or revoked. Each Insider’s biographical information furnished to the Company (including any such information
included in the Prospectus) is true and accurate in all respects and does not omit any material information with respect to the
Insider’s background. The Sponsor and each Insider’s questionnaire furnished to the Company is true and accurate in all
respects. The Sponsor and each Insider represents and warrants that: it, he or she is not subject to or a respondent in any legal
action for, any injunction, cease-and-desist order or order or stipulation to desist or refrain from any act or practice relating to
the offering of securities in any jurisdiction; it, he or she has never been convicted of, or pleaded guilty to, any crime (i)
involving fraud, (ii) relating to any financial transaction or handling of funds of another person, or (iii) pertaining to any
dealings in any securities and it, he or she is not currently a defendant in any such criminal proceeding. The Company represents
and warrants that, to its knowledge, (i) none of its advisors has been suspended or expelled from membership in any securities or
commodities exchange or association or had a securities or commodities license or registration denied, suspended or revoked, (ii)
each advisor’s biographical information furnished to the Company (including any such information included in the Prospectus)
is true and accurate in all respects and does not omit any material information with respect to such advisor’s background and
each advisor’s questionnaire furnished to the Company is true and accurate in all respects, (iii) none of its advisors is
subject to or a respondent in any legal action for, any injunction, cease-and-desist order or order or stipulation to desist or
refrain from any act or practice relating to the offering of securities in any jurisdiction; and (iii) none of its advisors has been
convicted of, or pleaded guilty to, any crime (x) involving fraud, (y) relating to any financial transaction or handling of funds of
another person, or (z) pertaining to any dealings in any securities and none of its advisors is currently a defendant in any such
criminal proceeding.

 

    		5	 

    	 

    

 

9.
            (a) Except as disclosed in the Prospectus and cash or other compensation to the Company’s officers or advisors to be engaged subsequent
to the consummation of the Public Offering (which will be disclosed in the Company’s other filings with the Securities and Exchange
Commission), neither the Sponsor nor any individual who is an officer, director or advisor of the Company as of the date hereof nor any
affiliate thereof shall receive from the Company any finder’s fee, reimbursement, consulting fee, monies in respect of any repayment
of a loan or other compensation prior to, or in connection with any services rendered in order to effectuate the consummation of the
Company’s initial Business Combination (regardless of the type of transaction that it is), other than the following, none of which
will be made from the proceeds held in the Trust Account prior to the completion of the initial Business Combination: repayment of a
loan and advances up to an aggregate of $300,000 made to the Company by our sponsor or an affiliate of our sponsor; reimbursement for
any out-of-pocket expenses related to identifying, investigating and consummating an initial Business Combination; payment to an affiliate
of the Sponsor of $10,000 per month, for up to 18 months, for office space, utilities and secretarial and administrative support; and
repayment of non-interest bearing loans, if any, and on such terms as to be determined by the Company from time to time, made by the
Sponsor or any of the Company’s officers or directors to finance transaction costs in connection with an intended initial Business
Combination, provided, that, if the Company does not consummate an initial Business Combination, a portion of the working capital held
outside the Trust Account may be used by the Company to repay such loaned amounts so long as no proceeds from the Trust Account are used
for such repayment. Up to $1,500,000 of such loans may be convertible into units, at a price of $10.00 per unit at the option of the
lender, upon consummation of the initial Business Combination. The units would be identical to the Private Placement Units. Additionally,
up to $1,000,000 (or $1,150,000 if the underwriters’ over-allotment option is exercised in full) may be loaned by the Sponsor to
fund up to two three-month extensions on the period of time in which the Company has to consummate a Business Combination. Such loans
may be convertible into units at a price of $10.00 per unit, which units would be identical to Private Placement Units.

 

10.
Each of the Sponsor and each Insider has full right and power, without violating any agreement to which it is bound (including,
without limitation, any non-competition or non-solicitation agreement with any employer or former employer), to enter into this
Letter Agreement and, as applicable, to serve as an officer and/or a director on the board of directors of the Company and hereby
consents to being named in the Prospectus as an officer and/or a director of the Company.

 

11.
As used herein, (i) “Business Combination” shall mean a merger, capital stock exchange, asset acquisition, stock purchase,
reorganization or similar business combination, involving the Company and one or more businesses; (ii) “Capital Stock” shall
mean, collectively, the Ordinary Shares and the Founder Shares; (iii) “Founder Shares” shall mean the 2,875,000 shares of
the Company’s Class B ordinary shares, par value $0.0001 per share, initially held by the Sponsor (up to 375,000 Shares of which
are subject to complete or partial forfeiture by the Sponsor if the over-allotment option is not exercised in full by the Underwriters);
(iv) “Initial Shareholders” shall mean the Sponsor and any other holder of Founder Shares immediately prior to the
Public Offering; (v) “Private Placement Shares” shall mean the 661,842 Ordinary Shares comprising the Private Placement Units
(or up to 736,842 Ordinary Shares if the over-allotment option is exercised in full); (vi) “Private Placement Units” shall
mean the 661,842 units to be purchased by the Sponsor, or up to 736,842 units if the over-allotment option is exercised in full, each
comprised of one Ordinary Share, one warrant to purchase one-half of one Ordinary Share, and one Right, that the Sponsor has agreed to
purchase for an aggregate purchase price of $6,618,420 (or up to $7,368,420 if the over-allotment option is exercised in full), for a
purchase price of $10.00 per Private Placement Unit, in a private placement that shall occur simultaneously with the consummation of
the Public Offering; (vii) “Private Placement Warrants” shall mean the Warrants to purchase up to 330,921 Ordinary Shares
(or up to 368,421 Ordinary Shares if the over-allotment option is exercised in full) comprising the Private Placement Units; (viii) “Private
Placement Rights shall mean the Rights to receive 66,184 Ordinary Shares (or up to 73,684 Ordinary Shares if the over-allotment option
is exercised in full) upon the consummation of the Business Combination (ix) “Public Shareholders” shall mean the
holders of securities issued in the Public Offering; (ix) “Trust Account” shall mean the trust fund into which a portion
of the net proceeds of the Public Offering and the sale of the Private Placement Units shall be deposited; and (xi) “Transfer”
shall mean the (a) sale or assignment of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase
or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position
or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Securities Exchange
Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder with respect to, any security, (b) entry
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any
security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public announcement
of any intention to effect any transaction specified in clause (a) or (b).

 

    		6	 

    	 

    

 

12.
This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter
hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to
the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may
not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by
a written instrument executed by all parties hereto.

 

13.
No party hereto may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior
written consent of the other parties. Any purported assignment in violation of this paragraph shall be void and ineffectual and
shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on
the Sponsor and each Insider and their respective successors, heirs and assigns and permitted transferees.

 

14.
Nothing in this Letter Agreement shall be construed to confer upon, or give to, any person or corporation other than the parties
hereto any right, remedy or claim under or by reason of this Letter Agreement or of any covenant, condition, stipulation, promise or
agreement hereof. All covenants, conditions, stipulations, promises and agreements contained in this Letter Agreement shall be for
the sole and exclusive benefit of the parties hereto and their successors, heirs, personal representatives and assigns and permitted
transferees.

 

15.
This Letter Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for
all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same
instrument.

 

16.
This Letter Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not
affect the validity or enforceability of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any
such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Letter
Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and
enforceable.

 

17.
This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without
giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.
The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this
Letter Agreement shall be brought and enforced in the courts of New York City, in the State of New York, and irrevocably submit to
such jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive
jurisdiction and venue or that such courts represent an inconvenient forum.

 

18.
Any notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in
writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand
delivery or facsimile transmission.

 

19.
This Letter Agreement shall terminate on the earlier of (i) the expiration of the Lock-up Periods or (ii) the liquidation of the
Company; provided, however, that this Letter Agreement shall earlier terminate in the event that the Public Offering is not
consummated and closed by [●], 2022; provided further that paragraph 4 of this Letter Agreement shall survive such
liquidation.

 

    		7	 

    	 

    

 

	 	Sincerely,
	 	 
	 	PROTONIQ
    Acquisition Corp
	 	 	 
	 	By:
    	 
	 	Name:	Babar
    Ali
	 	Title:	Chief
    Executive Officer
	 	 	 
	 	By:    	 
	 	Name:	Atle
    Crowe-Maxwell
	 	Title:	Chief
    Financial Officer
	 	 	 
	 	By:	 
	 	Name:	PROTONIQ
    LLC
	 	By:	Babar
    Ali, Manager
	 	 	 
	 	By:	 
	 	Name:	Brett
    Westbrook
	 	By:	Independent
    Director
	 	 	 
	 	By:	 
	 	Name:	Bharat
    Patel
	 	By:	Independent
    Director
	 	 	 
	 	By: 	 
	 	Name:	Marco
    Bardelli
	 	By:	Independent
    Director
	 	 	 
	 	By: 	 
	 	Name:	Denis
    Durand
	 	By:	Independent
    Director

 

    	Signature Page to Letter Agreement
	8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]